BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22897713)

  • 1. Consumption of national health insurance medical resources by hepatocellular carcinoma patients treated using radiofrequency ablation therapy.
    Kung CM; Mo LR; Yan YH
    Asia Pac J Clin Oncol; 2012 Sep; 8(3):275-81. PubMed ID: 22897713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health care costs associated with hepatocellular carcinoma: a population-based study.
    Thein HH; Isaranuwatchai W; Campitelli MA; Feld JJ; Yoshida E; Sherman M; Hoch JS; Peacock S; Krahn MD; Earle CC
    Hepatology; 2013 Oct; 58(4):1375-84. PubMed ID: 23300063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
    J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of radiofrequency ablation on the management of patients with hepatocellular carcinoma in a specialized centre.
    Lam CM; Ng KK; Poon RT; Ai V; Yuen J; Fan ST
    Br J Surg; 2004 Mar; 91(3):334-8. PubMed ID: 14991635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation].
    Wang YB; Chen MH; Yan K; Yang W; Dai Y; Yin SS
    Ai Zheng; 2005 Jul; 24(7):827-33. PubMed ID: 16004809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radiofrequency ablation for hepatocellular carcinoma and liver metastases].
    Yasumoto T; Murakami T; Katsumoto Y; Hashimoto T; Noda S; Murata K; Kinuta M; Nakamura H
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1596-9. PubMed ID: 16315881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma.
    Cheung TT; Ng KK; Poon RT; Fan ST
    J Hepatobiliary Pancreat Surg; 2009; 16(5):655-60. PubMed ID: 19370304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
    Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
    J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic-assisted microwave ablation for hepatocellular carcinoma: safety and efficacy in comparison with radiofrequency ablation.
    Simo KA; Sereika SE; Newton KN; Gerber DA
    J Surg Oncol; 2011 Dec; 104(7):822-9. PubMed ID: 21520094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?
    Zavaglia C; Corso R; Rampoldi A; Vinci M; Belli LS; Vangeli M; Solcia M; Castoldi C; Prisco C; Vanzulli A; Pinzello G
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):196-201. PubMed ID: 18301300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy.
    Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Huo TI; Huang YH; Wu WC; Lin HC; Lee SD; Wu JC
    J Clin Gastroenterol; 2012 Jan; 46(1):62-70. PubMed ID: 21934530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection.
    Kagawa T; Koizumi J; Kojima S; Nagata N; Numata M; Watanabe N; Watanabe T; Mine T;
    Cancer; 2010 Aug; 116(15):3638-44. PubMed ID: 20564097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitation of repeated radiofrequency ablation in hepatocellular carcinoma: proposal of a three (times) × 3 (years) index.
    Yokoyama K; Anan A; Iwata K; Nishizawa S; Morihara D; Ueda S; Sakurai K; Iwashita H; Hirano G; Sakamoto M; Takeyama Y; Irie M; Shakado S; Sohda T; Sakisaka S
    J Gastroenterol Hepatol; 2012 Jun; 27(6):1044-50. PubMed ID: 22433056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm].
    Yang MJ; An SY; Moon EJ; Lee MS; Hwang JA; Cheong JY; Won JH; Kim JK; Wang HJ; Cho SW
    Korean J Hepatol; 2009 Dec; 15(4):474-85. PubMed ID: 20037266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical radiofrequency ablation for treatment of hepatocellular carcinoma: an endoscopic or open approach.
    Tanaka S; Shimada M; Shirabe K; Taketomi A; Maehara S; Tsujita E; Ito S; Kitagawa D; Maehara Y
    Hepatogastroenterology; 2009; 56(93):1169-73. PubMed ID: 19760963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation with hand-assisted laparoscopic surgery for the treatment of hepatocellular carcinoma in the caudate lobe.
    Ishiko T; Beppu T; Sugiyama S; Masuda T; Takahashi M; Komori H; Takamori H; Hirota M; Kanemitu K; Baba H
    Surg Laparosc Endosc Percutan Tech; 2008 Jun; 18(3):272-6. PubMed ID: 18574414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity-based cost analysis of hepatic tumor ablation using CT-guided high-dose rate brachytherapy or CT-guided radiofrequency ablation in hepatocellular carcinoma.
    Schnapauff D; Collettini F; Steffen I; Wieners G; Hamm B; Gebauer B; Maurer MH
    Radiat Oncol; 2016 Feb; 11():26. PubMed ID: 26911437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency ablation for hepatocellular carcinoma induces glypican-3 peptide-specific cytotoxic T lymphocytes.
    Nobuoka D; Motomura Y; Shirakawa H; Yoshikawa T; Kuronuma T; Takahashi M; Nakachi K; Ishii H; Furuse J; Gotohda N; Takahashi S; Nakagohri T; Konishi M; Kinoshita T; Komori H; Baba H; Fujiwara T; Nakatsura T
    Int J Oncol; 2012 Jan; 40(1):63-70. PubMed ID: 21922136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lifetime cost of hepatocellular carcinoma : a claims data analysis from a medical centre in Taiwan.
    Lang HC; Wu JC; Yen SH; Lan CF; Wu SL
    Appl Health Econ Health Policy; 2008; 6(1):55-65. PubMed ID: 18774870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.